Martin Brochu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martin Brochu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Louise Béliveau
Université de Montréal, Montreal (Quebec), Canada
2 shared publications - Marie-Eve Mathieu
Université de Montréal
2 shared publications Antony D. Karelis
Department of Kinanthropology, University of Quebec at Montreal, Montreal, Quebec, Canada
1 shared publicationDominique Garrel
Department of Nutrition, University of Montreal, Montreal, Quebec, Canada
1 shared publicationMarie‐Eve Lavoie
Department of Nutrition, University of Montreal, Montreal, Quebec, Canada
1 shared publicationMarie‐Eve Mathieu
Department of Kinesiology, University of Montreal, Montreal, Quebec, Canada
1 shared publication
Latest Publications
- 1 September 2009
- Published by Taylor & Francis in Research Quarterly for Exercise and Sport
- Vol. 80 (3) , 583-592
The DiabetAction Program: Implementation in Community-Based Settings
- 1 September 2009
- Published by Taylor & Francis in Research Quarterly for Exercise and Sport
- Vol. 80 (3) , 583-592
The DiabetAction Program: Implementation in Community-Based Settings
- 1 September 2009
- Published by Taylor & Francis in Research Quarterly for Exercise and Sport
- Vol. 80 (3) , 583-592
The DiabetAction Program
Developed for specialists who want to increase the physical activity (PA) level of type 2 diabetic and at-risk individuals, the 10-week DiabetAction program introduced participants to a wide variety of cardiovascular, resistance, balance, and flexibility exercises. Thirty-three of 48 individuals completed the intervention in community-based settings, while 25 of 29 participants completed control group evaluations. A significant time effect (p < .05) was measured for leisure PA level, resting systolic and diastolic blood pressure, estimated aerobic capacity, and dynamic balance (nonsignificant group effect; p > .05). The physical functioning domain of quality of life improved in the experimental group, while the vitality domain improved in the control group (significant interactions; p < .05). Follow-ups of the experimental group revealed that they maintained postintervention parameters (leisure PA level, proportion of participants ≥ 150 min of PA weekly, estimated aerobic capacity) or improved (mental component summary measure of quality of life). Ninety-four percent of the experimental group was “very” or “extremely” satisfied with the program, and participants perceived improvements in PA level, health, and tiredness postintervention. In conclusion, participants in community-based settings improved on many of the measured parameters and maintained PA practice up to 6 months postintervention. However, since control participants also saw improvements, further controlled studies will be needed.
- 1 September 2009
- Published by Taylor & Francis in Research Quarterly for Exercise and Sport
- Vol. 80 (3) , 583-592
The DiabetAction Program
Developed for specialists who want to increase the physical activity (PA) level of type 2 diabetic and at-risk individuals, the 10-week DiabetAction program introduced participants to a wide variety of cardiovascular, resistance, balance, and flexibility exercises. Thirty-three of 48 individuals completed the intervention in community-based settings, while 25 of 29 participants completed control group evaluations. A significant time effect (p < .05) was measured for leisure PA level, resting systolic and diastolic blood pressure, estimated aerobic capacity, and dynamic balance (nonsignificant group effect; p > .05). The physical functioning domain of quality of life improved in the experimental group, while the vitality domain improved in the control group (significant interactions; p < .05). Follow-ups of the experimental group revealed that they maintained postintervention parameters (leisure PA level, proportion of participants ≥ 150 min of PA weekly, estimated aerobic capacity) or improved (mental component summary measure of quality of life). Ninety-four percent of the experimental group was “very” or “extremely” satisfied with the program, and participants perceived improvements in PA level, health, and tiredness postintervention. In conclusion, participants in community-based settings improved on many of the measured parameters and maintained PA practice up to 6 months postintervention. However, since control participants also saw improvements, further controlled studies will be needed.
Contribution of the Lean Body Mass to Insulin Resistance in Postmenopausal Women With Visceral Obesity: A Monet Study
Some insulin‐resistant obese postmenopausal (PM) women are characterized by an android body fat distribution type and higher levels of lean body mass (LBM) compared to insulin‐sensitive obese PM women. This study investigates the independent contribution of LBM to the detrimental effect of visceral fat (VF) levels on the metabolic profile. One hundred and three PM women (age: 58.0 ± 4.9 years) were studied and categorized in four groups on the basis of their VF (higher vs. lower) and lean BMI (LBMI = LBM (kg)/height (m2); higher vs. lower). Measures included: fasting lipids, glucose homeostasis (by euglycemic/hyperinsulinemic clamp technique and 2‐h oral glucose tolerance test (OGTT)), C‐reactive protein (CRP) levels, fat distribution (by computed tomography (CT) scan), and body composition (by dual‐energy X‐ray absorptiometry). Women in the higher VF/higher LBMI group had lower glucose disposal and higher plasma insulin levels compared to the other groups. They also had higher plasma CRP levels than the women in the lower VF/lower LBMI group. VF was independently associated with insulin levels, measures of glucose disposal, and CRP levels (P < 0.05). LBMI was also independently associated with insulin levels, glucose disposal, and CRP levels (P < 0.05). Finally, significant interactions were observed between LBMI and VF levels for insulin levels during the OGTT and measures of glucose disposal (P < 0.05). In conclusion, VF and LBMI are both independently associated with alterations in glucose homeostasis and CRP levels. The contribution of VF to insulin resistance seems to be exacerbated by increased LBM in PM women.
Contribution of the Lean Body Mass to Insulin Resistance in Postmenopausal Women With Visceral Obesity: A Monet Study
Some insulin‐resistant obese postmenopausal (PM) women are characterized by an android body fat distribution type and higher levels of lean body mass (LBM) compared to insulin‐sensitive obese PM women. This study investigates the independent contribution of LBM to the detrimental effect of visceral fat (VF) levels on the metabolic profile. One hundred and three PM women (age: 58.0 ± 4.9 years) were studied and categorized in four groups on the basis of their VF (higher vs. lower) and lean BMI (LBMI = LBM (kg)/height (m2); higher vs. lower). Measures included: fasting lipids, glucose homeostasis (by euglycemic/hyperinsulinemic clamp technique and 2‐h oral glucose tolerance test (OGTT)), C‐reactive protein (CRP) levels, fat distribution (by computed tomography (CT) scan), and body composition (by dual‐energy X‐ray absorptiometry). Women in the higher VF/higher LBMI group had lower glucose disposal and higher plasma insulin levels compared to the other groups. They also had higher plasma CRP levels than the women in the lower VF/lower LBMI group. VF was independently associated with insulin levels, measures of glucose disposal, and CRP levels (P < 0.05). LBMI was also independently associated with insulin levels, glucose disposal, and CRP levels (P < 0.05). Finally, significant interactions were observed between LBMI and VF levels for insulin levels during the OGTT and measures of glucose disposal (P < 0.05). In conclusion, VF and LBMI are both independently associated with alterations in glucose homeostasis and CRP levels. The contribution of VF to insulin resistance seems to be exacerbated by increased LBM in PM women.